ALKBH5 and intrahepatic cholangiocarcinoma: Qiu et al. recently reported the immunomodulatory role of the demethylase ALKBH5 in intrahepatic cholangiocarcinoma’s (iCCA) immune microenvironment [83], which showed that PD-L1 was subject to post-transcriptional regulation mediated by m6A modification.